Web Analytics

3 Latest Announced Rounds

  • $4,100,000
    Seed

    3 Investors

    Software Development
    Sep 19th, 2025
  • $2,600,000
    Pre-Seed

    1 Investors

    Travel Arrangements
    Sep 19th, 2025
  • $34,000,000
    Series B
    Construction
    Sep 19th, 2025
$1,441.27M Raised in 60 Funding Rounds in the past 7 Days - View All

Funding Round Profile

Immunai

start up
United States - New York, NY
  • 28/10/2021
  • Series B
  • $215,000,000

Comprehensively mapping and reprogramming the immune system with single-cell biology and AI to power new therapeutic discoveries, accelerate drug development and improve patient outcomes


Related People

Noam SolomonFounder

Noam Solomon Israel - Tel Aviv-Yafo, Tel Aviv,

N/A